Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212179) titled 'Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery' on Sept. 29.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Anas El Fathi
Condition:
Type 1 Diabetes
Intervention:
Device: AID + InsuLearn-SMA
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2025
Target Sample Size: 6
Countries of Recruitment:
United States
To know more, visit ...